AAAAAA

   
Results: 1-6 |
Results: 6

Authors: DINGEMANSE J WALLNOFER A GIESCHKE R GUENTERT T AMREIN R
Citation: J. Dingemanse et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN FLUOXETINE AND MOCLOBEMIDE IN THE INVESTIGATION OF DEVELOPMENT OF THE SEROTONIN SYNDROME, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 403-413

Authors: GIESCHKE R REIGNER BG STEIMER JL
Citation: R. Gieschke et al., EXPLORING CLINICAL-STUDY DESIGN BY COMPUTER-SIMULATION BASED ON PHARMACOKINETIC PHARMACODYNAMIC MODELING/, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 469-474

Authors: DINGEMANSE J GUENTERT T GIESCHKE R STABL M
Citation: J. Dingemanse et al., MODIFICATION OF THE CARDIOVASCULAR EFFECTS OF EPHEDRINE BY THE REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR MOCLOBEMIDE, Journal of cardiovascular pharmacology, 28(6), 1996, pp. 856-861

Authors: DINGEMANSE J BURY M RONCARI G ZELL M GIESCHKE R GAILLARD AWK ODINK J VANBRUMMELEN P
Citation: J. Dingemanse et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-41-3696, A NOVEL NONBENZODIAZEPINE HYPNOTIC, Journal of clinical pharmacology, 35(8), 1995, pp. 821-829

Authors: DINGEMANSE J JORGA KM SCHMITT M GIESCHKE R FOTTELER B ZURCHER G DAPRADA M VANBRUMMELEN P
Citation: J. Dingemanse et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE DURING FIRST ADMINISTRATION TO HUMANS, Clinical pharmacology and therapeutics, 57(5), 1995, pp. 508-517

Authors: GIESCHKE R CLUYDTS R DINGEMANSE J DEROECK J DECOCK W
Citation: R. Gieschke et al., EFFECTS OF BRETAZENIL VS ZOLPIDEM AND PLACEBO ON EXPERIMENTALLY-INDUCED SLEEP DISTURBANCE IN HEALTHY-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 16(9), 1994, pp. 667-675
Risultati: 1-6 |